Asthma and COPD Drugs Market: New Investment Opportunities Emerge To Augment Segments in Healthcare Sector By 2023
(WorldNews Health)

`Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022´´, projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America accounted around for around half of the Global Asthma and COPD Drugs market share in 2015. Increase in incidence and prevalence of asthma and COPD, growing geriatric population, technological advancement in the treatment...